| Acute Myeloid Leukemia Research | Lifetime | 176 | US 92 | 99.44 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 78 | US 41 | 99.30 |
| Hematological disorders and diagnostics | Lifetime | 99 | US 56 | 98.33 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 215 | US 112 | 98.89 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 442 | US 212 | 98.77 |
| Eosinophilic Disorders and Syndromes | Lifetime | 165 | US 84 | 98.54 |
| Hemoglobinopathies and Related Disorders | Lifetime | 687 | US 352 | 96.88 |
| Mast cells and histamine | Lifetime | 666 | US 223 | 94.47 |
| Retinoids in leukemia and cellular processes | Lifetime | 817 | US 393 | 94.27 |
| Histone Deacetylase Inhibitors Research | Lifetime | 857 | US 381 | 93.34 |
| Kruppel-like factors research | Lifetime | 393 | US 154 | 93.10 |
| Blood disorders and treatments | Lifetime | 669 | US 268 | 93.39 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 219 | US 54 | 93.90 |
| Telomeres, Telomerase, and Senescence | Lifetime | 951 | US 350 | 88.70 |
| Vascular Anomalies and Treatments | Lifetime | 658 | US 236 | 86.53 |
| Acute Myeloid Leukemia Research | 2021-2025 | 25 | US 18 | 99.74 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 15 | US 12 | 99.55 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 57 | US 37 | 98.91 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 16 | US 7 | 97.80 |
| Hematological disorders and diagnostics | 2021-2025 | 18 | US 13 | 94.70 |
| Cancer Genomics and Diagnostics | 2021-2025 | 659 | US 292 | 95.95 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 358 | US 158 | 96.27 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 470 | US 207 | 95.94 |
| Vascular Anomalies and Treatments | 2021-2025 | 43 | US 13 | 92.82 |
| Blood disorders and treatments | 2021-2025 | 92 | US 26 | 91.93 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 191 | US 94 | 91.66 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 73 | US 32 | 87.92 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 550 | US 259 | 89.78 |
| Telomeres, Telomerase, and Senescence | 2021-2025 | 186 | US 85 | 85.09 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 481 | US 146 | 83.50 |
| Protein Degradation and Inhibitors | 2021-2025 | 927 | US 388 | 84.90 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 913 | US 366 | 86.54 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 543 | US 110 | 81.04 |
| Histiocytic Disorders and Treatments | 2021-2025 | 128 | US 55 | 77.75 |
| Science, Research, and Medicine | 2021-2025 | 231 | US 78 | 35.35 |
